2) TSHR
促甲状腺激素激素受体
1.
Structure of thyrotropin-stimulating hormone receptor(TSHR) was introduced in the paper as a primary antigen of autoimmune thyroid disease(AITD),it induced TSHR-Abs produce.
本文扼要介绍促甲状腺激素激素受体(TSHR)结构,作为一种自身免疫性甲状腺疾病(AITD)主要抗原,它与促甲状腺激素受体抗体(TSHR-Abs)结合后,触发一系列生物化学级联反应,持续地刺激甲状腺细胞合成与释放甲状腺激素(T3T4)的增加,最终诱发Grave's病(GD),同时也介绍了一些当前推出的GD病人血清中TSHR-Abs检测新方法。
4) TRAb
促甲状腺激素受体抗体
1.
Clinical Value of Determination of Serum Thyrotrophin Receptor Antibody (TRAb) Levels in Patients with Thyroid Diseases;
促甲状腺激素受体抗体(TRAb)测定的临床价值
2.
Methods The levels of serum TRAb and TSAb w ere tested by ELISA after administrating oral iodized capsule.
为探讨补碘对缺碘机体甲状腺自身免疫的影响,采用酶联免疫分析方法测定了缺碘地区人群口服碘油前后的促甲状腺激素受体抗体(TRAb)和甲状腺刺激抗体(TSAb)水平变化。
3.
Objective: there is a transitory increase in levels of thyrotrophic receptors antibodies (TRAb) after radioiodine therapy (~(131)I) in hyperthyroid Graves disease, Immunosuppressive effects of anti thyroid drugs (ATD) are still a matter of debate.
目的 Graves病患者~(131)I治疗后血清促甲状腺激素受体抗体(TRAb)有短暂升高，抗甲状腺药物(ATD)的是否具有免疫调节作用目前仍存在争论，本研究通过观察ATD干预治疗对~(131)I治疗后血清TRAb的影响，探讨ATD的免疫调节作用及TRAb与预后的关系。
5) Thyroid stimulating hormone receptor
促甲状腺激素受体
1.
Objective To investigate the association of the expressions of thyroid stimulating hormone receptor(TSHR)and Na+/I-symportor(NIS)with aberrant hypermethylation and T1799A BRAF mutation in papillary thyroid cancer(PTC).
目的探讨甲状腺乳头状癌(PTC)中促甲状腺激素受体(TSHR)和钠/碘协同转运体(NIS)蛋白表达与相应基因的甲基化及T1799A BRAF基因突变的关系。
6) Thyrotropin receptor
促甲状腺激素受体
1.
Expression of thyrotropin receptor in differentiated thyroid carcinoma tissue;
分化型甲状腺癌组织中促甲状腺激素受体的表达
2.
In situ expression of thyrotropin receptor in the extraocular muscles of patients with thyroid-associated ophthalmopathy;
促甲状腺激素受体在甲状腺相关眼病眼外肌原位表达的研究(英文)
3.
Objective The study was designed to anayze the characteristics of thyrotropin receptor Gs protein adenylate cyclase signal transduction system in nonfunctioning thyroid tumors and to prove that the functional status of these tumors was not associated with this signal system.
目的通过研究无功能性甲状腺肿瘤促甲状腺激素受体（ＴＳＨＲ）剌激性Ｇ蛋白（Ｇｓ蛋白）腺苷酸环化酶（ＡＣ）信息传递系统的特性，证明该肿瘤的发生与此信息传递系统无显著相关。
补充资料：促甲状腺激素受体抗体
促甲状腺激素受体抗体
〖HT5”SS〗thyroid sti?mulating hormone receptor antibody TSHRAb
又称“甲状腺刺激性抗体”(TSAb）。可竞争性抑制TSH与TSH受体结合，能兴奋甲状腺滤泡细胞促甲状腺激素受体，促使甲状腺细胞增生，分泌亢进，引起毒性甲状腺肿或桥本甲状腺炎。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条